copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Home - Zenas BioPharma Leading With Intention Our commitment to being a leader in the development and commercialization of therapies for autoimmune diseases is clear With our exceptional team, we believe we can Explore the Zenas Experience
Who We Are - Zenas BioPharma Zenas BioPharma is committed to being a leader in the development and commercialization of transformative therapies for autoimmune diseases so that patients with autoimmune diseases can reimagine life
Pipeline - Zenas BioPharma Zenas is committed to being a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases We are advancing a balanced portfolio of complementary mechanisms and modalities with best-in-class blockbuster potential across multiple therapeutic areas
News - Zenas BioPharma Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology
Job Openings - Zenas BioPharma Learn more about our open positions and how you can become part of the Zenas experience Together, we can reimage life for patients with autoimmune diseases worldwide
Zenas BioPharma Announces Upsized $200 Million Series C Financing to . . . Zenas BioPharma is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology (I I) directed therapies for patients in need around the world
Investor Media Relations | Zenas BioPharma, Inc Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases
Zenas BioPharma Launches as a Cross-Border Biopharmaceutical Company to . . . HONG KONG and BOSTON, March 23, 2021 (GLOBE NEWSWIRE) — Zenas BioPharma (“Zenas”) launched today as a cross-border biopharmaceutical company committed to becoming a global leader in the development and delivery of immune-based therapies for patients in China and throughout the world
SEC Filings | Zenas BioPharma, Inc View financial statements and other formal documents submitted to the U S Securities and Exchange Commission (SEC) for Zenas BioPharma, Inc